Technology used in development of Pfizer, Moderna COVID-19 vaccines could prevent fatal heart attacks – WJXT News4JAX

JACKSONVILLE, Fla.– The same innovation used to help Pfizer and Moderna develop their COVID-19 vaccines could prevent fatal cardiac arrest, according to medical professionals at the Jacksonville Center for Clinical Research.The Pfizer and Moderna COVID-19 vaccines utilize bioengineered ribonucleic acid to deceive individualss bodies into combating the virus. Scientists at the Jacksonville Center for Clinical Research say they have actually now discovered to use that very same innovation to prevent the production of a protein linked to fatal heart attacks.Lipoprotein(a), likewise understood as Lp(a), is described by medical professionals as the wicked twin of low-density lipoproteins (LDL), commonly referred to as bad cholesterol. Lp(a) has an additional protein coil that burrows into the wall of arteries, causing blood clots and inflammation. This raises the possibilities of establishing cardiovascular illness and suffering a lethal cardiovascular disease or stroke.Dr. Michal Koren is both a cardiologist and the director of research at the Jacksonville Center for Clinical Research. His research in bioengineered ribonucleic acid assisted Pfizer and Moderna establish their COVID-19 vaccines. He says the exact same technology appears to work against Lp(a). Advertisement”When it comes to the COVID-19 vaccines, were using RNA messaging to improve the signal to expose the body immune system to the spike protein. When we handle cholesterol problems, were using RNA technology to obstruct messages, so our bodies do not produce that bad chemical,” Koren said.Koren says individuals who have high levels of Lp(a) might not understand they have it because its not routinely evaluated. People who have actually suffered cardiovascular disease or stroke in their 30s or 40s are normally discovered to have higher levels of Lp(a). Super high levels of Lp(a) combined with other cholesterol levels have been found in clients much more youthful. Koren says this protein is typically genetic.”Half of the member of the family of an index case might also have this problem, so thats why its essential to understand the hereditary relationships of people within a family, particularly if someone has actually had a cardiovascular disease or stroke at a young age,” Koren said.AdThe RNA treatment that is currently being researched involves an injection much like the COVID-19 vaccine. If the treatment is authorized by the Food and Drug Administration, people with high levels of Lp(a) will no longer have to undergo plasmapheresis, a process that filters the blood just like a dialysis machine that filters the kidneys.Copyright 2021 by WJXT News4Jax – All rights scheduled.